Showing results (211-220 of 535) with videos related to
Sort By:
Pageof 54
Cancer Gene Therapy|August 5, 2000
Impact of liver P450 reductase suppression on cyclophosphamide activation, pharmacokinetics and antitumoral activity in a cytochrome P450-based cancer gene therapy modelZ Huang, M K Raychowdhury, D J WaxmanThe Journal of Pharmacology and Experimental Therapeutics|July 1, 1995
Modulation of thiotepa antitumor activity in vivo by alteration of liver cytochrome P450-catalyzed drug metabolismT K Chang, G Chen, D J WaxmanBiochemistry|August 2, 2006
Computational solvent mapping reveals the importance of local conformational changes for broad substrate specificity in mammalian cytochromes P450Karl H Clodfelter, David J Waxman, Sandor VajdaBMC Cancer|September 15, 2010
Adenoviral delivery of pan-caspase inhibitor p35 enhances bystander killing by P450 gene-directed enzyme prodrug therapy using cyclophosphamide+Joshua C Doloff, Ting Su, David J WaxmanCancer Research|November 14, 1997
Potentiation of cytochrome P450/cyclophosphamide-based cancer gene therapy by coexpression of the P450 reductase geneL Chen, L J Yu, D J WaxmanMolecular Endocrinology (Baltimore, Md.)|December 20, 2003
Sexual dimorphism of rat liver gene expression: regulatory role of growth hormone revealed by deoxyribonucleic Acid microarray analysisAmrita Ahluwalia, Karl H Clodfelter, David J WaxmanThe Journal of Biological Chemistry|December 10, 1980
Linear, uncross-linked peptidoglycan secreted by penicillin-treated Bacillus subtilis. Isolation and characterization as a substrate for penicillin-sensitive D-alanine carboxypeptidasesD J Waxman, W Yu, J L StromingerToxicological Sciences : an Official Journal of the Society of Toxicology|April 5, 2018
Impact of CAR Agonist Ligand TCPOBOP on Mouse Liver Chromatin AccessibilityNicholas J Lodato, Andy Rampersaud, David J WaxmanMolecular Pharmacology|April 18, 2001
Transcriptional induction of hepatic NADPH: cytochrome P450 oxidoreductase by thyroid hormoneH C Li, D Liu, D J WaxmanCancer Gene Therapy|July 23, 2003
Sustained P450 expression and prodrug activation in bolus cyclophosphamide-treated cultured tumor cells. Impact of prodrug schedule on P450 gene-directed enzyme prodrug therapyPamela S Schwartz, Chong-Sheng Chen, David J WaxmanPageof 54